Otsuka Pharmaceutical Development & Commercialization, Inc.
Records under this name other than the patents Otsuka Pharmaceutical Development & Commercialization, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Otsuka Pharmaceutical Development & Commercialization, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,830,615 | Device-Based Risk Management of a Therapeutic conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 10,412,089 | Device-Based Risk Management of a Therapeutic conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,551,790 | Systems, Devices, and Methods for Ingestible Event Sensing and Analysis conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,564,885 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,759,426 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,980,690 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same conveyed to Otsuka Pharmaceutical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 12,156,941 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same conveyed to Otsuka Pharmaceutical Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 12,370,144 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same conveyed to Otsuka Pharmaceutical Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| 15/946,691 | System and Methods for Data Driven Document Creation and Modification Abandoned Abandoned Nov 15, 2021 | Abandoned | Abandoned Nov 15, 2021 | |
| 17/533,061 | Methods and Compositions for Treating Autosomal Dominant Polycystic Kidney Disease conveyed to Otsuka Pharmaceutical Co., Ltd. Abandoned Abandoned Mar 4, 2024 | Abandoned | Abandoned Mar 4, 2024 |